Effect of D-glucose on nitric oxide release from glomerular endothelial cells

Diabetes/Metabolism Research and Reviews

Volumn 17, Issue 3, 2001, Pages 217-222

  Kasai, Nobuhiko ^a   Sugimoto, Kazuhiro ^a   Horiba, Nobuo ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Diabetic nephropathy; Glomerular endothelial cell; Hyperglycemia; Nitric oxide

Indexed keywords

ARGININE; GLUCOSE; MANNITOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLOMERULUS; HYPERGLYCEMIA; METABOLITE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ARGININE; CATTLE; CELL LINE, TRANSFORMED; ENDOTHELIUM, VASCULAR; GLUCOSE; HYPERGLYCEMIA; KIDNEY GLOMERULUS; KINETICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITES; SIMIAN VIRUS 40;

EID: 0034947220     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.195     Document Type: Article

References (53)

1. Endothelial cells in physiology and in the pathophysiology of vascular disorders
2. The biology of the glomerulus: Endothelial cells
3. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics
4. Renal hemodynamics in recent-onset type II diabetes
5. Kidney function and size in diabetics before and during initial insulin treatment
6. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes
7. Glomerular hemodynamics in experimental diabetes mellitus
8. The nature of endothelium-derived vascular relaxant factor
9. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture
10. Nitric oxide as a secretory product of mammalian cells
11. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme
12. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
13. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
14. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
15. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
16. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis
17. Role of nitric oxide in angiogenesis and microcirculation in tumors
18. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor
19. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney
20. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney
21. Hormonal modulation of glomerular function
22. Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF
23. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyper-filtration of diabetic nephropathy
24. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy
25. Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats
26. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response
27. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response
28. Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells
29. Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophage like nitric oxide synthases are expressed and activities regulated by glucose concentration
30. Glomerular endothelial injury associated with free radical production induced by a fungal cell wall component, (1→3) beta-D glucan
31. Establishment and characterization of an immortalized bovine glomerular endothelial cell line
32. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
33. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells
34. Practical nitric oxide measurement employing a nitric oxide-selective electrode
35. Role of NO generation in beta-adrenoceptor-mediated stimulation of rabbit airway ciliary motility
36. A fluorometric assay for the measurement of nitrite in biological samples
37. Intracellular mechanisms involved in D-glucose-mediated amplification of agonist-induced Ca2+ response and EDRF formation in vascular endothelial cells
38. Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells
39. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products
40. High glucose inhibits nitric oxide production in cultured rat mesangial cells
41. Protein kinase C activation and the development of diabetic complications
42. Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture
43. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites
44. Inhibition of endothelial nitric oxide synthase activity by protein kinase C
45. The linked roles of nitric oxide, aldose reductase and (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
46. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes
47. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes
48. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
49. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
50. Extracellular superoxide dismutase: A regulator of nitric oxide bioavailability
51. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
52. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals
53. Impaired nitric oxide release by glomeruli from diabetic rats